CD22 is not expressed merely on B cells: comment on the article by Vos et al.
Teng
Y K O
YK
Engels
M C
MC
van Laar
J M
JM
van Laar
Y M
YM
D000911:Antibodies, Monoclonal / Q000494:pharmacology; D058846:Antibodies, Monoclonal, Murine-Derived; D018941:Antigens, CD19 / Q000378:metabolism; D018951:Antigens, CD20 / Q000378:metabolism; D018501:Antirheumatic Agents / Q000494:pharmacology; D001172:Arthritis, Rheumatoid / Q000209:etiology / Q000276:immunology* / Q000473:pathology*; D016175:B-Lymphocyte Subsets / Q000276:immunology / Q000473:pathology; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology* / Q000473:pathology*; D006801:Humans; D000069283:Rituximab; D012680:Sensitivity and Specificity; D051918:Sialic Acid Binding Ig-like Lectin 2 / Q000378:metabolism*; D013583:Synovial Membrane / Q000276:immunology / Q000473:pathology
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018941:Antigens, CD19; D018951:Antigens, CD20; D018501:Antirheumatic Agents; D051918:Sialic Acid Binding Ig-like Lectin 2; D000069283:Rituximab